- Fee assured
- Awaiting verification
Neal Navani qualified in Medicine from Cambridge and UCL with distinction and several University prizes. He trained in Respiratory Medicine at the Brompton and Hammersmith Hospitals before winning a Medical Research Council Fellowship in 2008 and completing his PhD at UCL in 2011. He has also completed an MSc in Clinical Trials at the London School of Hygiene and Tropical Medicine. Dr Navani was appointed as a Consultant in Thoracic Medicine at University College London and runs the regional Bronchoscopy and Endobronchial Ultrasound (EBUS) service at UCLH. He is also clinical lead for the prestigious lung cancer service at UCLH.
Dr Navani runs several clinical trials on the diagnosis and staging of lung disease and bronchoscopic techniques. He holds honorary positions at the Medical Research Council Clinical Trials Unit and University College London and is also a member of the UCLH early lung cancer detection and surveillance programme. His research is patient focused and aims to improve the patient experience and outcomes.
Dr Navani has authored numerous peer-reviewed publications and is the co-author of a textbook on respiratory disorders. He is an invited member of a NICE technology assessment group, the British Thoracic Society guideline development group for bronchoscopy and is a peer reviewer for many journals including the BMJ, Thorax and AJRCCM.
Areas of interest
Respiratory medicine, bronchoscopy, endobronchial ultrasound, cough, asthma, bronchiectasis, pneumonia, breathlessness, COPD, emphysema, tuberculosis, sarcoidosis, lung cancer, pulmonary embolism, pneumothorax, clinical trials.
Current NHS consultant posts held
University College London Hospitals
Early diagnosis of lung cancer, staging techniques for lung cancer, diagnosis of lung diseases. Dr Navani has led the UK in research into Endobronchial Ultrasound for diagnosing lung conditions
Dr Navani is the author of numerous publications, book chapters and a textbook of Respiratory Medicine.
EBUS-TBNA Prevents Mediastinoscopies in the Diagnosis of Isolated Mediastinal Lymphadenopathy: A Prospective Trial. Navani N et al. Am J Respir Crit Care Med. 2012 Aug 1; 186(3): 255-260
Screening for lung cancer: is this the way forward? Spiro SG and Navani N.
Respirology 2012; 17(2): 237-46.
- MA University Of Cambridge 1999
- MBBS University College London 2000
- MSc London School of Hygeine and Tropical Medicine 2011
- PhD University College London 2011
- FRCP Royal College of Physicians 2015
Reference number 4723679
Affiliations / memberships
MA, MSc, PhD, FRCP
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Contact details will be provided to the member prior to treatment